
New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome
Author(s) -
Elena Morozova,
Nikolai Tsvetkov,
M.V. Barabanshchikova,
Ksenia Yurovskaya,
Ivan Moiseev
Publication year - 2022
Publication title -
onkogematologiâ
Language(s) - English
Resource type - Journals
eISSN - 2413-4023
pISSN - 1818-8346
DOI - 10.17650/1818-8346-2022-17-4-106-117
Subject(s) - myelodysplastic syndromes , medicine , transplantation , epigenetic therapy , disease , immunotherapy , clinical trial , hematopoietic stem cell transplantation , targeted therapy , oncology , immunology , intensive care medicine , bioinformatics , cancer , biology , dna methylation , bone marrow , biochemistry , gene expression , gene